Ceftazidime Injection, Powder, For Solution
Product Images NDC 44567-237

2 FDA label images from Wg Critical Care, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ceftazidime (NDC 44567-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of ceftazidime, showing its molecular framework including a beta-lactam ring, side chains, and a pentahydrate (5H2O) component, as depicted in the diagram.*
FDA Label Image

Ceftazidime For Injection 6 G Vial Label (Image 02)

Ceftazidime For Injection 6 G Vial Label (Image 02)
Ceftazidime 6 g/vial injection, powder for solution, intravenous use. This label shows a single-dose vial packaging from WG Critical Care, LLC. The label includes directions for reconstitution, storage instructions, a barcode, and a note that it is a pharmacy bulk package not for direct infusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.